Severe maternal morbidity events in first pregnancy were associated with a significantly reduced likelihood of subsequent delivery.

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...

COVID-19 infection is associated with accelerated decline in kidney function, especially after hospitalization.

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Significant association between rheumatoid arthritis and increased chronic obstructive pulmonary disease risk seen in both genders, seropositive/seronegative ...

Disease-modifying therapy use for MS in pregnancy is associated with certain adverse outcomes, including small for gestational age.

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

A recent study finds that the prevalence of post-COVID-19 condition was 8.4 percent among U.S. adults in 2023.

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.

COVID-19 infection is not associated with immediate changes in multiple sclerosis symptom severity or disability.